Pharmacological promotion of inclusion formation: A therapeutic approach for Huntington’s and Parkinson’s diseases
Ruth A. Bodner(Center for Cancer Research), Aleksey Kazantsev(Harvard University), Tiago F. Outeiro(German Center for Neurodegenerative Diseases), Stephen M. Altmann(Scripps Research Institute), Bradley T. Hyman(Harvard University), David E. Housman(Massachusetts Institute of Technology), Anne B. Young, Pamela J. McLean(Mayo Clinic in Florida), Michele M. Maxwell(Scripps Research Institute), Stephanie Cho(Center for Cancer Research)
Cited by 258
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
|NeuroImage|2006|14.1k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k